In our study, we found RPS6KA2 was related to the prognosis of ovarian cancer through TCGA, GSE26712 and GSE26193, the highly expression of RPS6KA2 had a better prognosis in ovarian cancer. Here, RPS6KA2 is linked to ovarian carcinoma.